CALCIUM ET MAGNESIUM TAB TABLET Kanada - angol - Health Canada

calcium et magnesium tab tablet

laboratoire lalco inc. - calcium (calcium carbonate); magnesium (magnesium carbonate) - tablet - 160mg; 80mg - calcium (calcium carbonate) 160mg; magnesium (magnesium carbonate) 80mg - minerals

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

Magnesium trisilicate oral suspension Egyesült Királyság - angol - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium trisilicate oral suspension

thornton & ross ltd - magnesium trisilicate; magnesium carbonate light; sodium bicarbonate - oral suspension - 50mg/1ml ; 50mg/1ml ; 50mg/1ml

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

remedyrepack inc. - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

medical purchasing solutions, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

MAGNESIUM SULFATE- magnesium sulfate heptahydrate injection, solution Egyesült Államok - angol - NLM (National Library of Medicine)

magnesium sulfate- magnesium sulfate heptahydrate injection, solution

fresenius kabi usa, llc - magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838) - magnesium sulfate heptahydrate 500 mg in 1 ml - magnesium sulfate injection, usp is suitable for replacement therapy in magnesium deficiency, especially in acute hypomagnesemia accompanied by signs of tetany similar to those observed in hypocalcemia.  in such cases, the serum magnesium level is usually below the lower limit of normal (1.5 to 2.5 meq/l) and the serum calcium level is normal (4.3 to 5.3 meq/l) or elevated. in total parenteral nutrition (tpn), magnesium sulfate may be added to the nutrient admixture to correct or prevent hypomagnesemia which can arise during the course of therapy. magnesium sulfate injection is also indicated for the prevention and control of seizures in a pre-eclampsia and eclampsia, respectively. parenteral administration of the drug is contraindicated in patients with heart block or myocardial damage.

BICARBONATE DE SODIUM 4,2 % B. BRAUN, solution pour perfusion Franciaország - francia - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

bicarbonate de sodium 4,2 % b. braun, solution pour perfusion

laboratoire b braun medical - bicarbonate de sodium 4 - solution - 4,20 g - pour 100 ml de solution pour perfusion > bicarbonate de sodium 4,20 g - sang et organes hematopoÏetiques/substituts du sang et solutions de perfusion/additifs pour solutions intraveineuses/solutions d’electrolytes/bicarbonate de sodium - classe pharmacothérapeutique sang et organes hematopoÏetiques/substituts du sang et solutions de perfusion/additifs pour solutions intraveineuses/solutions d’electrolytes/bicarbonate de sodium - code atc : b05xa02ce médicament est utilisé : en cas d’acidose métabolique (taux de substances acides dans le sang trop élevé), pour alcaliniser (rendre plus basique) l’urine en cas d’intoxication par des substances acides comme le phénobarbital ou l’acide acétylsalicylique afin d’accélérer leur excrétion, pour alcaliniser (rendre plus basique) l’urine afin d’augmenter la solubilité de médicaments comme le méthotrexate et les sulfamides pour améliorer leur excrétion, pour alcaliniser (rendre plus basique) l’urine afin de prévenir le blocage des reins par les fragments d’hémoglobine en cas de destruction massive des globules rouges (hémolyse).

BICARBONATE DE SODIUM 1,4 % B.BRAUN, solution pour perfusion Franciaország - francia - ANSM (Agence Nationale de Sécurité du Médicament et des Produits de Santé)

bicarbonate de sodium 1,4 % b.braun, solution pour perfusion

laboratoire b braun medical - bicarbonate de sodium 1 - solution - 1,40 g - pour 100 ml de solution injectable > bicarbonate de sodium 1,40 g - sang et organes hematopoÏetiques/substituts du sang et solutions de perfusion/additifs pour solutions intraveineuses/solutions d’electrolytes/bicarbonate de sodium - classe pharmacothérapeutique : sang et organes hematopoÏetiques/substituts du sang et solutions de perfusion/additifs pour solutions intraveineuses/solutions d’electrolytes/bicarbonate de sodium - code atc : b05xa02ce médicament est utilisé : en cas d’acidose métabolique (taux de substances acides dans le sang trop élevé), pour alcaliniser (rendre plus basique) l’urine en cas d’intoxication par des substances acides comme le phénobarbital ou l’acide acétylsalicylique afin d’accélérer leur excrétion, pour alcaliniser (rendre plus basique) l’urine afin d’augmenter la solubilité de médicaments comme le méthotrexate et les sulfamides pour améliorer leur excrétion, pour alcaliniser (rendre plus basique) l’urine afin de prévenir le blocage des reins par les fragments d’hémoglobine en cas de destruction massive des globules rouges (hémolyse).